UA26893C2 - Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей - Google Patents
Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солейInfo
- Publication number
- UA26893C2 UA26893C2 UA93002172A UA93002172A UA26893C2 UA 26893 C2 UA26893 C2 UA 26893C2 UA 93002172 A UA93002172 A UA 93002172A UA 93002172 A UA93002172 A UA 93002172A UA 26893 C2 UA26893 C2 UA 26893C2
- Authority
- UA
- Ukraine
- Prior art keywords
- formula
- methyl
- group
- chem
- adhesetroxy
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- -1 2-methyl-1H-imidazol-1-yl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 2
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical class C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 229960005343 ondansetron Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9203223A HU212785B (en) | 1992-10-14 | 1992-10-14 | Process for producing of a carbazolone derivative |
HU9203222A HU212934B (en) | 1992-10-14 | 1992-10-14 | Process for producing novel alkoxalylated carbazolone derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
UA26893C2 true UA26893C2 (uk) | 1999-12-29 |
Family
ID=26318102
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA93002172A UA26893C2 (uk) | 1992-10-14 | 1993-10-11 | Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей |
UA99052847A UA27022C2 (uk) | 1992-10-14 | 1999-05-24 | Похідhі карбазолоhу як проміжhі сполуки для отримаhhя оhдаhсетроhу |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UA99052847A UA27022C2 (uk) | 1992-10-14 | 1999-05-24 | Похідhі карбазолоhу як проміжhі сполуки для отримаhhя оhдаhсетроhу |
Country Status (20)
Country | Link |
---|---|
US (2) | US5416221A (uk) |
EP (1) | EP0595111B2 (uk) |
JP (1) | JP3378315B2 (uk) |
KR (1) | KR100289912B1 (uk) |
CN (2) | CN1052979C (uk) |
AT (1) | ATE157973T1 (uk) |
CA (1) | CA2106642C (uk) |
CZ (1) | CZ284223B6 (uk) |
DE (1) | DE69313771T3 (uk) |
DK (1) | DK0595111T4 (uk) |
EE (1) | EE03071B1 (uk) |
ES (1) | ES2106936T5 (uk) |
GR (1) | GR3025599T3 (uk) |
HR (1) | HRP931292B1 (uk) |
PL (2) | PL174173B1 (uk) |
RO (1) | RO115799B1 (uk) |
RU (1) | RU2119914C1 (uk) |
SI (1) | SI9300537B (uk) |
SK (1) | SK281243B6 (uk) |
UA (2) | UA26893C2 (uk) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU226135B1 (en) * | 2000-03-28 | 2008-05-28 | Richter Gedeon Nyrt | Intermediate of ondansetron and process for its production |
KR100368895B1 (ko) * | 2000-03-30 | 2003-01-24 | 하나제약 주식회사 | 1,2,3,9-테트라하이드로-9-메틸-3-[(2-메틸-1h-이미다졸-1-일)메틸]-4h-카바졸-4-온의 제조방법 |
YU32003A (sh) * | 2000-10-30 | 2006-05-25 | Teva Pharmaceutical Industries Ltd. | Novi kristalni i solvatni oblici ondansteron hlorovodonika i postupci za njihovo pripremanje |
EP1207160A1 (en) * | 2000-11-20 | 2002-05-22 | Hanmi Pharm. Co., Ltd. | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one |
EP1499623B1 (en) * | 2002-04-29 | 2007-06-13 | TEVA Gyógyszergyár Zártkörüen Müködö Részvénytársaság | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-¬(2-methyl-1h-imidazol-1-yl)methyl|-4h-carbazol-4-one |
JP2005529908A (ja) * | 2002-04-30 | 2005-10-06 | テバ ジョジセルジャール レースベニュタールシャシャーグ | オンダンセトロンの新規結晶形、その製法、当該新規形を含有する医薬組成物、及び当該組成物を用いる吐気の治療方法 |
US20050131045A1 (en) * | 2002-04-30 | 2005-06-16 | Judith Aronhime | Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them |
FI6164U1 (fi) * | 2003-01-09 | 2004-03-15 | Synthon Bv | Ondansetronmuotoja |
US7390503B1 (en) | 2003-08-22 | 2008-06-24 | Barr Laboratories, Inc. | Ondansetron orally disintegrating tablets |
JP2008505965A (ja) * | 2004-07-12 | 2008-02-28 | カディラ ヘルスケア リミティド | カンナビノイド受容体修飾因子としての三環式ピラゾール誘導体 |
US7696356B2 (en) * | 2004-08-17 | 2010-04-13 | Taro Pharmaceutical Industries Limited | Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom |
WO2006046253A1 (en) * | 2004-10-26 | 2006-05-04 | Ipca Laboratories Limited | A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o |
CN115677561B (zh) * | 2022-11-01 | 2024-04-05 | 常州兰陵制药有限公司 | 一种1,2,3,4-四氢-9-甲基-4h-咔唑酮及其合成方法 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3579534A (en) * | 1969-05-09 | 1971-05-18 | American Cyanamid Co | Tetrahydrocarbazolecarboxylates |
IT1182150B (it) * | 1984-01-25 | 1987-09-30 | Glaxo Group Ltd | Composti eterociclici tetraidrocarbozolonici, procedimenti per preparli e composizioni farmaceutiche che li contengono |
CN1011237B (zh) * | 1984-01-25 | 1991-01-16 | 格拉克索公司 | 1,2,3,9-四氢-3-[(2-甲基-1h-咪唑-1-基)甲基]-4h-咔唑-4-酮类和其盐以及溶剂化物的制备 |
GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
GB8518742D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Process |
GB8617994D0 (en) * | 1986-07-23 | 1986-08-28 | Glaxo Group Ltd | Heterocyclic compounds |
GB8628473D0 (en) * | 1986-11-28 | 1987-01-07 | Glaxo Group Ltd | Chemical compounds |
JPH01258673A (ja) * | 1987-10-22 | 1989-10-16 | Glaxo Group Ltd | ケトン誘導体 |
-
1993
- 1993-09-21 CA CA002106642A patent/CA2106642C/en not_active Expired - Fee Related
- 1993-10-08 HR HR3223/92A patent/HRP931292B1/xx not_active IP Right Cessation
- 1993-10-11 UA UA93002172A patent/UA26893C2/uk unknown
- 1993-10-13 ES ES93116542T patent/ES2106936T5/es not_active Expired - Lifetime
- 1993-10-13 PL PL93300685A patent/PL174173B1/pl not_active IP Right Cessation
- 1993-10-13 DE DE69313771T patent/DE69313771T3/de not_active Expired - Fee Related
- 1993-10-13 EP EP93116542A patent/EP0595111B2/en not_active Expired - Lifetime
- 1993-10-13 JP JP25588093A patent/JP3378315B2/ja not_active Expired - Fee Related
- 1993-10-13 DK DK93116542T patent/DK0595111T4/da active
- 1993-10-13 CZ CZ932156A patent/CZ284223B6/cs not_active IP Right Cessation
- 1993-10-13 CN CN93119192A patent/CN1052979C/zh not_active Expired - Fee Related
- 1993-10-13 KR KR1019930021223A patent/KR100289912B1/ko not_active IP Right Cessation
- 1993-10-13 RU RU93049416A patent/RU2119914C1/ru not_active IP Right Cessation
- 1993-10-13 RO RO93-01370A patent/RO115799B1/ro unknown
- 1993-10-13 PL PL93324329A patent/PL174526B1/pl not_active IP Right Cessation
- 1993-10-13 SK SK1110-93A patent/SK281243B6/sk unknown
- 1993-10-13 US US08/135,407 patent/US5416221A/en not_active Expired - Lifetime
- 1993-10-13 AT AT93116542T patent/ATE157973T1/de not_active IP Right Cessation
- 1993-10-13 SI SI9300537A patent/SI9300537B/sl not_active IP Right Cessation
-
1994
- 1994-07-19 EE EE9400092A patent/EE03071B1/xx not_active IP Right Cessation
- 1994-11-25 US US08/344,871 patent/US5478949A/en not_active Expired - Lifetime
-
1997
- 1997-12-04 GR GR970403244T patent/GR3025599T3/el unknown
-
1999
- 1999-05-11 CN CN99106445A patent/CN1083430C/zh not_active Expired - Fee Related
- 1999-05-24 UA UA99052847A patent/UA27022C2/uk unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW262474B (uk) | ||
FI914163A0 (fi) | Heterocykliska derivat. | |
IL127296A (en) | Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them | |
HU9401943D0 (en) | Process for producing amide and urea derivatives and compositions containing them | |
UA26893C2 (uk) | Спосіб отримаhhя оhдасетроhу та його фармацевтичhо прийhятhих солей | |
DK0625147T3 (da) | Fremgangsmåde til fremstilling af taxanderivater | |
ES2157214T3 (es) | Procedimiento para producir derivados de azetidinona sustituidos en posicion 4. | |
EP0937726A4 (en) | INTERMEDIATE PRODUCTS FOR PRODUCING DUOCARMYCIN-SA AND DERIVATIVES THEREOF, AND A METHOD FOR PRODUCING THE INTERIM PRODUCTS | |
IL102093A0 (en) | 1-methylcarbapenem derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same | |
PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
AU1811988A (en) | A process for the preparation of substituted indolin-2-one derivatives | |
HUT59378A (en) | Process for producing urea derivatives and pharmaceutical compositions comprising such compounds | |
HU9200172D0 (en) | Substituted 1,2,3,4-tetrahydro-cyclopenta/b/indole-and 1,2,3,3a,4,8a-hexahydro-cyclopenta/b/indole derivatives, their intermediate products, process for their production and medical preparations containing them | |
PL287073A1 (en) | Method of obtaining novel derivatives of benzanilide | |
FI896251A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten pyratsolopyridiinijohdannaisten valmistamiseksi | |
ATE120743T1 (de) | Pyridoindolderivate und verfahren zu ihrer herstellung. | |
ATE168371T1 (de) | 5-amino-5,6,7,8-tetrahydrochinoline und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
HUT45059A (en) | Process for producing abeoergoline derivatives | |
ZA924888B (en) | Process for the synthesis of enantiomers of 3-aminochroman compounds | |
AU2639999A (en) | Intermediate compounds in the synthesis of the a ring moiety of 2-substituted vitamin d derivatives | |
ATE131480T1 (de) | Pyrimidoindolderivate und verfahren zu ihrer herstellung | |
HU904013D0 (en) | Process for producing substituted 3-amino-sydnonimine derivatives and pharmaceutical preparatives containing these | |
ES8600760A1 (es) | Procedimiento para preparar 2-((3, 4-metilendioxi)-fenetil)-5-((3-carboxamido-4-hidroxi)- -hidroxibencil)-pirrolidina |